3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
17
Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
3
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Respiratory Tract Diseases
1
Papillary renal cell carcinoma, sporadic
1
Pancreatic Intraductal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms, Squamous Cell
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Hereditary leiomyomatosis and renal cell cancer
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
fludarabine
2
Patient Reported Outcome Measures
2
Mesna
2
Colposcopy
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Thalidomide
1
Tamoxifen
1
Sirolimus
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Nivolumab
1
Methotrexate
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Erlotinib Hydrochloride
×
1 year
×
Clear all
No trials found.